Biomarkers of Diabetes

Biomarkers are molecular markers used as direct or indirect markers of the extent of a disease. HbA1c is considered as the biomarker in diabetes for assessing the risk factor related to retinopathy, nephropathy and other vascular diseases. Biomarkers enable preventive measures to be applied at the subclinical stage and the responses to preventive or therapeutic measures to be monitored.

  • Novel Biomarkers
  • Advances in Molecular Diagnostics
  • HbA1c Biomarker

Related Conference of Biomarkers of Diabetes

November 11-12, 2019

Annual Congress on Diabetes, Metabolism and Obesity

Sydney, Australia
December 04-05, 2019

3rd Annual Congress on Diabetes and Its Complications

Tokyo, Japan
December 9,10,2019

International Congress and Expo on Diabetic Care

Bangkok,Thailand
December 12-13, 2019

Annual Congress on Diabetes and Endocrinology

Dubai, UAE
January 27-28, 2020

Global Summit On Diabetes & Endocrinology

Bangkok, Thailand
March 25-26, 2020

29th World Diabetes & Heart Congress

| Radisson Narita | Tokyo, Japan
March 27-28, 2020

Annual Summit on Metabolomics

Amsterdam, Netherlands
April 17-18, 2020

3rd Global Meeting on Diabetes and Endocrinology

Kualalumpur, Malaysia
June 15-16, 2020

29thEuropean Diabetes Congress

| Barcelona, Spain
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

| Copenhagen, Denmark
June 14-15, 2021

diabetic 2021

Abu Dhabi, UAE

Biomarkers of Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in